Animal Vaccines Market (By Product: Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines , Recombinant Vaccines; By Animal Type: Poultry, Aqua, Ruminants, Companion, Feline, Swine) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Animal Vaccines Market, By Product

7.1.  Animal Vaccines Market, By Product, 2021-2030

7.1.1.    Attenuated Live Vaccines

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Inactivated Vaccines

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Subunit Vaccines

7.1.3.1.        Market Revenue and Forecast (2016-2030)

7.1.4.    DNA Vaccines

7.1.4.1.        Market Revenue and Forecast (2016-2030)

7.1.5.    Recombinant Vaccines

7.1.5.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Animal Vaccines Market, By Animal Type

8.1.  Animal Vaccines Market, By Animal Type, 2021-2030

8.1.1.    Poultry

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Aqua

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Ruminants

8.1.3.1.        Market Revenue and Forecast (2016-2030)

8.1.4.    Companion

8.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Animal Vaccines Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, By Product (2016-2030)

9.1.2.    Market Revenue and Forecast, By Animal Type (2016-2030)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, By Product (2016-2030)

9.1.3.2.        Market Revenue and Forecast, By Animal Type (2016-2030)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, By Product (2016-2030)

9.1.4.2.        Market Revenue and Forecast, By Animal Type (2016-2030)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, By Product (2016-2030)

9.2.2.    Market Revenue and Forecast, By Animal Type (2016-2030)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, By Product (2016-2030)

9.2.3.2.        Market Revenue and Forecast, By Animal Type (2016-2030)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, By Product (2016-2030)

9.2.4.2.        Market Revenue and Forecast, By Animal Type (2016-2030)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, By Product (2016-2030)

9.2.5.2.        Market Revenue and Forecast, By Animal Type (2016-2030)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, By Product (2016-2030)

9.2.6.2.        Market Revenue and Forecast, By Animal Type (2016-2030)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, By Product (2016-2030)

9.3.2.    Market Revenue and Forecast, By Animal Type (2016-2030)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, By Product (2016-2030)

9.3.3.2.        Market Revenue and Forecast, By Animal Type (2016-2030)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, By Product (2016-2030)

9.3.4.2.        Market Revenue and Forecast, By Animal Type (2016-2030)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, By Product (2016-2030)

9.3.5.2.        Market Revenue and Forecast, By Animal Type (2016-2030)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, By Product (2016-2030)

9.3.6.2.        Market Revenue and Forecast, By Animal Type (2016-2030)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, By Product (2016-2030)

9.4.2.    Market Revenue and Forecast, By Animal Type (2016-2030)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, By Product (2016-2030)

9.4.3.2.        Market Revenue and Forecast, By Animal Type (2016-2030)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, By Product (2016-2030)

9.4.4.2.        Market Revenue and Forecast, By Animal Type (2016-2030)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, By Product (2016-2030)

9.4.5.2.        Market Revenue and Forecast, By Animal Type (2016-2030)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, By Product (2016-2030)

9.4.6.2.        Market Revenue and Forecast, By Animal Type (2016-2030)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, By Product (2016-2030)

9.5.2.    Market Revenue and Forecast, By Animal Type (2016-2030)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, By Product (2016-2030)

9.5.3.2.        Market Revenue and Forecast, By Animal Type (2016-2030)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, By Product (2016-2030)

9.5.4.2.        Market Revenue and Forecast, By Animal Type (2016-2030)

Chapter 10.  Company Profiles

10.1.              Zoetis

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              Virbac Inc

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              Indian Immunological Limited

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Heska Corp.

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Boehringer Inghlem

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              Bayer Pharma Ag

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              Merck Animal Health

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Biogenesis Bago

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms